Close

Chardan Capital Markets Downgrades Opexa Therapeutics (OPXA) to Neutral

October 28, 2016 11:25 AM EDT Send to a Friend
Chardan Capital Markets downgraded Opexa Therapeutics (NASDAQ: OPXA) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login